269 related articles for article (PubMed ID: 31202670)
21. Clinical indications and biological mechanisms of splenic irradiation in autoimmune diseases.
Weinmann M; Becker G; Einsele H; Bamberg M
Strahlenther Onkol; 2001 Feb; 177(2):105-11. PubMed ID: 11233832
[TBL] [Abstract][Full Text] [Related]
22. A case of idiopathic thrombocytopenia and autoimmune hemolytic anemia treated with thymic irradiation and by administration of imuran and actinomycin-C.
RICHMOND J; WOODRUFF MF; CUMMING RA; DONALD KW
Lancet; 1963 Jul; 2(7299):125-8. PubMed ID: 13982164
[No Abstract] [Full Text] [Related]
23. Management of autoimmune cytopenia complicating chronic lymphocytic leukemia.
Zent CS; Shanafelt T
Leuk Lymphoma; 2009 Jun; 50(6):863-4. PubMed ID: 19455465
[No Abstract] [Full Text] [Related]
24. Autoimmune hemolytic anemia and immune thrombocytopenia as unusual presentations of childhood Hodgkin lymphoma: a case report and review of the literature.
Cecinati V; Brugnoletti F; D'Angiò M; De Nicolò MC; De Vellis A; Coluzzi S; Testi AM
J Pediatr Hematol Oncol; 2012 May; 34(4):280-2. PubMed ID: 22258348
[TBL] [Abstract][Full Text] [Related]
25. Successful use of rituximab in Evans syndrome and refractory immune thrombocytopenic purpura.
Kashif M; Qureshi A; Adil SN; Khurshid M
J Pak Med Assoc; 2010 Jan; 60(1):64-5. PubMed ID: 20055286
[TBL] [Abstract][Full Text] [Related]
26. Evan's syndrome complicating multicentric Castleman's disease -- dramatic response to rituximab.
Quinn JP; Gilligan OM; Horgan M
Eur J Haematol; 2004 Nov; 73(5):384-5. PubMed ID: 15458520
[No Abstract] [Full Text] [Related]
27. [The effect of immunocorrective therapy on immunity in patients with idiopathic autoimmune cytopenias].
Tishchenko LM
Vrach Delo; 1991 Aug; (8):60-3. PubMed ID: 1949738
[TBL] [Abstract][Full Text] [Related]
28. [Effective danazol therapy for a patient with Evans syndrome].
Koike M; Ishiyama T; Saito K; Osawa H; Hashimoto M; Wakabayashi Y; Tsuruoka N
Rinsho Ketsueki; 1993 Feb; 34(2):143-6. PubMed ID: 8492411
[TBL] [Abstract][Full Text] [Related]
29. Combination chemotherapy in a patient with severe multiple systemic autoimmune disease.
Tamai Y; Takami H; Akagi T; Kawamura S; Munakata A
Clin Lab Haematol; 1998 Oct; 20(5):315-6. PubMed ID: 9807680
[TBL] [Abstract][Full Text] [Related]
30. Bortezomib for autoimmune hemolytic anemia after intestinal transplantation.
Knops N; Emonds MP; Herman J; Levtchenko E; Mekahli D; Pirenne J; Van Geet C; Dierickx D
Pediatr Transplant; 2020 Jun; 24(4):e13700. PubMed ID: 32166874
[TBL] [Abstract][Full Text] [Related]
31. Successful treatment of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation with bortezomib.
Cao L; Koh LP; Linn YC
Leuk Lymphoma; 2018 Oct; 59(10):2500-2502. PubMed ID: 29345206
[No Abstract] [Full Text] [Related]
32. Bortezomib and daratumumab in refractory autoimmune hemolytic anemia.
McGlothlin J; Abeykoon J; Al-Hattab E; Ashrani AA; Elliott M; Hook CC; Pardanani A; Pruthi R; Sridharan M; Wolanskyj A; Rouse R; Go R
Am J Hematol; 2023 Oct; 98(10):E263-E265. PubMed ID: 37417424
[No Abstract] [Full Text] [Related]
33. [Evans syndrome in infants].
Flores-Montes OA; Escobar-Orduño MC; Lozano-Garcidueñas M; Valle-Leal JG
Bol Med Hosp Infant Mex; 2017; 74(2):141-146. PubMed ID: 29382497
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of children with chronic immune thrombocytopenic purpura and Evans syndrome treated with rituximab.
Gokcebay DG; Tavil B; Fettah A; Yarali N; Azik FM; Tunc B
Clin Appl Thromb Hemost; 2013; 19(6):663-7. PubMed ID: 22815318
[TBL] [Abstract][Full Text] [Related]
35. Successful treatment of Evans syndrome post liver transplant with splenectomy and switch from tacrolimus to cyclosporine.
Domenech C; Mialou V; Galambrun C; Lachaux A; Mure P; Dijoud F; Bertrand Y
Transpl Int; 2008 Apr; 21(4):397-9. PubMed ID: 18167150
[No Abstract] [Full Text] [Related]
36. [A case of Evans's syndrome in which thrombocytopenia and hemolysis was improved by Sairei-to].
Horikoshi A; Shida M; Abe M; Hosokawa Y; Sawada S; Horie T
Rinsho Ketsueki; 1995 Oct; 36(10):1237-9. PubMed ID: 8531338
[TBL] [Abstract][Full Text] [Related]
37. ITP Is Neither Idiopathic nor Always Benign.
Konda M; Fletcher M; Warrier R
Clin Pediatr (Phila); 2021 Mar; 60(3):193-194. PubMed ID: 33305594
[No Abstract] [Full Text] [Related]
38. Low-dose rituximab and alemtuzumab combination therapy for patients with steroid-refractory autoimmune cytopenias.
Gómez-Almaguer D; Solano-Genesta M; Tarín-Arzaga L; Herrera-Garza JL; Cantú-Rodríguez OG; Gutiérrez-Aguirre CH; Jaime-Pérez JC
Blood; 2010 Dec; 116(23):4783-5. PubMed ID: 20841509
[TBL] [Abstract][Full Text] [Related]
39. Severe Evans's syndrome secondary to interleukin-2 therapy: treatment with chimeric monoclonal anti-CD20 antibody.
Abdel-Raheem MM; Potti A; Kobrinsky N
Ann Hematol; 2001 Sep; 80(9):543-5. PubMed ID: 11669305
[TBL] [Abstract][Full Text] [Related]
40. Bortezomib treatment of steroid-refractory Evans syndrome in children.
Beydoun SB; Persaud Y; Lafferty J; Callaghan MU; Savaşan S
Pediatr Blood Cancer; 2020 Dec; 67(12):e28725. PubMed ID: 32969165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
